HK1152652A1 - Pharmaceutical solid preparation having active ingredients separated by boundary therein - Google Patents

Pharmaceutical solid preparation having active ingredients separated by boundary therein

Info

Publication number
HK1152652A1
HK1152652A1 HK11106770.0A HK11106770A HK1152652A1 HK 1152652 A1 HK1152652 A1 HK 1152652A1 HK 11106770 A HK11106770 A HK 11106770A HK 1152652 A1 HK1152652 A1 HK 1152652A1
Authority
HK
Hong Kong
Prior art keywords
boundary
active ingredients
solid preparation
pharmaceutical solid
ingredients separated
Prior art date
Application number
HK11106770.0A
Other languages
English (en)
Inventor
Takeshi Matsushita
Ken Matsubara
Azusa Narita
Yusuke Mochizuki
Original Assignee
Daiichi Sankyo Healthcare Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41797176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1152652(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Healthcare Co filed Critical Daiichi Sankyo Healthcare Co
Publication of HK1152652A1 publication Critical patent/HK1152652A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11106770.0A 2008-09-05 2011-07-04 Pharmaceutical solid preparation having active ingredients separated by boundary therein HK1152652A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008227971 2008-09-05
PCT/JP2009/065390 WO2010027010A1 (fr) 2008-09-05 2009-09-03 Préparation pharmaceutique solide contenant des ingrédients actifs séparés par une frontière interne

Publications (1)

Publication Number Publication Date
HK1152652A1 true HK1152652A1 (en) 2012-03-09

Family

ID=41797176

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11106770.0A HK1152652A1 (en) 2008-09-05 2011-07-04 Pharmaceutical solid preparation having active ingredients separated by boundary therein

Country Status (9)

Country Link
EP (1) EP2335698B8 (fr)
JP (1) JP5579066B2 (fr)
KR (1) KR101640958B1 (fr)
CN (1) CN102137664B (fr)
BR (1) BRPI0919194A2 (fr)
HK (1) HK1152652A1 (fr)
MX (1) MX2011002400A (fr)
TW (1) TWI436763B (fr)
WO (1) WO2010027010A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0918539A2 (pt) * 2008-09-12 2015-12-08 Daiichi Sankyo Healthcare Co preparação farmacêutica sólida para administração oral
EP2695605B1 (fr) 2012-08-07 2017-05-03 Parapharm Development Ltd. Composition d'acide tranexamique
CN103054861A (zh) * 2012-12-29 2013-04-24 北京阜康仁生物制药科技有限公司 一种含氨甲环酸的复方固体制剂
CN109793757B (zh) * 2019-03-28 2021-06-22 北京刷新活力健康科技有限公司 一种抑制皮肤瘢痕生长的组合物及其制备方法和应用
JP2021001126A (ja) * 2019-06-20 2021-01-07 小林製薬株式会社 ケラチノサイト内メラノソーム分解促進剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102073A (ja) * 1987-10-15 1989-04-19 Takeda Chem Ind Ltd 安定なアスコルビン酸粉末およびその製造法
JPH04243825A (ja) 1991-01-25 1992-08-31 Ss Pharmaceut Co Ltd 色素沈着症治療剤
TW271406B (fr) * 1992-04-17 1996-03-01 Takeda Pharm Industry Co Ltd
JP2001294524A (ja) * 2000-04-12 2001-10-23 Taisho Pharmaceut Co Ltd アセトアミノフェン配合内服固形製剤
JP4786127B2 (ja) * 2002-07-12 2011-10-05 任康 高田 色素沈着改善治療薬
JP2004217655A (ja) * 2002-12-27 2004-08-05 Dai Ichi Seiyaku Co Ltd 美白用組成物
KR20080022592A (ko) * 2002-12-27 2008-03-11 다이이찌 세이야꾸 가부시기가이샤 미백용 조성물
US8277844B2 (en) * 2003-08-20 2012-10-02 Shionogi & Co., Ltd. Coating composition
JP2005314403A (ja) * 2004-03-31 2005-11-10 Dai Ichi Seiyaku Co Ltd 新規美白用組成物
WO2006003965A1 (fr) * 2004-06-30 2006-01-12 Daiichi Sankyo Healthcare Co., Ltd. Compositions blanchissant la peau
JP4768404B2 (ja) * 2005-11-08 2011-09-07 株式会社 資生堂 イオントフォレーシスによる美容方法
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤

Also Published As

Publication number Publication date
CN102137664A (zh) 2011-07-27
JP5579066B2 (ja) 2014-08-27
TW201016213A (en) 2010-05-01
EP2335698B8 (fr) 2014-06-25
BRPI0919194A2 (pt) 2015-12-15
JPWO2010027010A1 (ja) 2012-02-02
EP2335698A4 (fr) 2011-10-12
WO2010027010A1 (fr) 2010-03-11
KR20110057145A (ko) 2011-05-31
CN102137664B (zh) 2014-08-06
MX2011002400A (es) 2011-04-07
EP2335698A1 (fr) 2011-06-22
TWI436763B (zh) 2014-05-11
KR101640958B1 (ko) 2016-07-19
EP2335698B1 (fr) 2014-03-26

Similar Documents

Publication Publication Date Title
EP2130552A4 (fr) Composition pharmaceutique comportant un anticorps anti-grp 78 en tant qu'ingredient actif
ZA201005015B (en) Solid pharmaceutical dosage form
ZA201006029B (en) Pharmaceutical dosage form
IL208370A0 (en) Improved formulations for poorly permeable active pharmaceutical ingredients
EP2561892A4 (fr) Préparation solide aisément administrable
EP2447253A4 (fr) Composés de dihydropyrimidine et leurs procédés de préparation, leurs compositions pharmaceutiques et leurs utilisations
ZA201104348B (en) Pharmaceutical preparation
EP2468771A4 (fr) Composition pharmaceutique contenant un anticorps anti-hb-egf comme ingrédient actif
WO2009135593A3 (fr) Formulation pharmaceutique solide à libération retardée
IL213452A0 (en) Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
EP2241569A4 (fr) Composés de thiénopyridazine, leurs préparations, compositions pharmaceutiques et utilisations
ZA200903858B (en) Pharmaceutical dosage form
ZA201102715B (en) Solid pharmaceutical composition
GB0815972D0 (en) Pharmaceutical preparation
EP2504331A4 (fr) Composé, certaines nouvelles formes de celui-ci, compositions pharmaceutiques de celui-ci et procédés de préparation et d'utilisation
IL219617A0 (en) Pharmaceutical solid dosage form
EP2306998A4 (fr) Formulation pharmaceutique
EP2002828A4 (fr) Preparation pharmaceutique solide
IL213671A0 (en) Pharmaceutical composition comprising aleglitazar
HK1152652A1 (en) Pharmaceutical solid preparation having active ingredients separated by boundary therein
IL208788A (en) Pharmacy-based formulation
ZA201100871B (en) Solid pharmaceutical composition
IL212171A (en) 1-Phenylpyrol compounds, pharmaceuticals containing them and their use
IL206739A (en) An injectable drug containing silitol as an active substance
IL213200A0 (en) Acetals as parfuming ingredients